This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A. D. B.: The Ketogenic Diet in Epilepsy. Can. Med. Assoc. J., 1931, 24: 106–107.A. D. B.: The Ketogenic Diet in Epilepsy. Can. Med. Assoc. J., 1931, 24: 106–107.Search in Google Scholar
Ahn W.K., Park S., Kim H.D.: Protein-Losing Enteropathy as a Complication of the Ketogenic Diet. Yonsei Med. J., 2017, 58: 891–893. doi: 10.3349/ymj.2017.58.4.891.AhnW.K.ParkS.KimH.D.: Protein-Losing Enteropathy as a Complication of the Ketogenic Diet. Yonsei Med. J., 2017, 58: 891–893. doi: 10.3349/ymj.2017.58.4.891.Open DOISearch in Google Scholar
Appavu B., Vanatta L., Condie J., Kerrigan J.F., Jarrar R.: Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure, 2016, 41: 62–65. doi: 10.1016/j.seizure.2016.07.006.AppavuB.VanattaL.CondieJ.KerriganJ.F.JarrarR.: Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure, 2016, 41: 62–65. doi: 10.1016/j.seizure.2016.07.006.Open DOISearch in Google Scholar
Archer J., Warren A.E.L., Jackson G.D., Abbott D.: Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front. Neurol., 2014, 5: 225. doi: 10.3389/fneur.2014.00225.ArcherJ.WarrenA.E.L.JacksonG.D.AbbottD.: Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front. Neurol., 2014, 5: 225. doi: 10.3389/fneur.2014.00225.Open DOISearch in Google Scholar
Arslan N., Guzel O., Kose E., Yılmaz U., Kuyum P., Aksoy B., Çalık T.: Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy? Seizure, 2016, 43: 32–38. doi: 10.1016/j.seizure.2016.10.024.ArslanN.GuzelO.KoseE.YılmazU.KuyumP.AksoyB.ÇalıkT.: Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy?Seizure, 2016, 43: 32–38. doi: 10.1016/j.seizure.2016.10.024.Open DOISearch in Google Scholar
Arsov T., Mullen S.A., Damiano J.A., Lawrence K.M., Huh L.L., Nolan M. et al.: Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia, 2012a, 53: e204–e207. doi: 10.1111/epi.12007.ArsovT.MullenS.A.DamianoJ.A.LawrenceK.M.HuhL.L.NolanM.: Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia, 2012a, 53: e204–e207. doi: 10.1111/epi.12007.Open DOISearch in Google Scholar
Arsov T., Mullen S.A., Rogers S., Phillips A.M., Lawrence K.M., Damiano J.A. et al.: Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann. Neurol., 2012b, 72: 807–815. doi: 10.1002/ana.23702.ArsovT.MullenS.A.RogersS.PhillipsA.M.LawrenceK.M.DamianoJ.A.: Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann. Neurol., 2012b, 72: 807–815. doi: 10.1002/ana.23702.Open DOISearch in Google Scholar
Asadi-Pooya A.A.: Lennox-Gastaut syndrome: a comprehensive review. Neurol. Sci., 2018, 39: 403–414. doi: 10.1007/s10072-017-3188-y.Asadi-PooyaA.A.: Lennox-Gastaut syndrome: a comprehensive review. Neurol. Sci., 2018, 39: 403–414. doi: 10.1007/s10072-017-3188-y.Open DOISearch in Google Scholar
Ashrafi M.R., Hosseini S.A., Zamani G.R., Mohammadi M., Tavassoli A., Badv R.S. et al: The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula-based powder. Acta Neurol. Belg., 2017, 117: 175–182. doi: 10.1007/s13760-016-0732-0.AshrafiM.R.HosseiniS.A.ZamaniG.R.MohammadiM.TavassoliA.BadvR.S.: The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula-based powder. Acta Neurol. Belg., 2017, 117: 175–182. doi: 10.1007/s13760-016-0732-0.Open DOISearch in Google Scholar
Azevedo de Lima P., Baldini Prudêncio M., Murakami D.K., Pereira de Brito Sampaio L., Figueiredo Neto A.M., Teixeira Damasceno N.R.: Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition, 2017, 33: 271–277. doi: 10.1016/j.nut.2016.06.016.Azevedo de LimaP.Baldini PrudêncioM.MurakamiD.K.Pereira de Brito SampaioL.Figueiredo NetoA.M.Teixeira DamascenoN.R.: Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition, 2017, 33: 271–277. doi: 10.1016/j.nut.2016.06.016.Open DOISearch in Google Scholar
Azevedo de Lima P., Pereira de Brito Sampaio L., Teixeira Damasceno N.R.: Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo), 2014, 69: 699–705. doi: 10.6061/clinics/2014(10)09.Azevedo de LimaP.Pereira de Brito SampaioL.Teixeira DamascenoN.R.: Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo), 2014, 69: 699–705. doi: 10.6061/clinics/2014(10)09.Open DOISearch in Google Scholar
Ballaban-Gil K., Callahan C., O’Dell C., Pappo M., Moshé S., Shinnar S.: Complications of the ketogenic diet. Epilepsia, 1998, 39: 744–748.Ballaban-GilK.CallahanC.O’DellC.PappoM.MoshéS.ShinnarS.: Complications of the ketogenic diet. Epilepsia, 1998, 39: 744–748.10.1111/j.1528-1157.1998.tb01160.x9670903Search in Google Scholar
Barañano K.W., Hartman A.L.: The Ketogenic Diet: in Epilepsy and Other Neurologic Illnesses. Curr. Treat. Options Neurol., 2008, 10: 410–419.BarañanoK.W.HartmanA.L.: The Ketogenic Diet: in Epilepsy and Other Neurologic Illnesses. Curr. Treat. Options Neurol., 2008, 10: 410–419.10.1007/s11940-008-0043-8289856518990309Search in Google Scholar
Bergqvist A.G.C.: Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res., 2012, 100: 258–260. doi:10.1016/j.epilepsyres.2011.04.009.BergqvistA.G.C.: Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res., 2012, 100: 258–260. doi:10.1016/j.epilepsyres.2011.04.009.Open DOISearch in Google Scholar
Bergqvist A.G.C., Schall J.I., Gallagher P.R., Cnaan A., Stallings V.A.: Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia, 2005, 46: 1810–1819. doi: 10.1111/j.1528-1167.2005.00282.x.BergqvistA.G.C.SchallJ.I.GallagherP.R.CnaanA.StallingsV.A.: Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia, 2005, 46: 1810–1819. doi: 10.1111/j.1528-1167.2005.00282.x.16302862Open DOISearch in Google Scholar
Bergqvist A.G.C., Schall J.I., Stallings V.A., Zemel B.S.: Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am. J. Clin. Nutr., 2008, 88: 1678–1684. doi: 10.3945/ajcn.2008.26099.BergqvistA.G.C.SchallJ.I.StallingsV.A.ZemelB.S.: Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am. J. Clin. Nutr., 2008, 88: 1678–1684. doi: 10.3945/ajcn.2008.26099.19064531Open DOISearch in Google Scholar
Boison D.: New insights into the mechanism of the ketogenic diet. Curr. Opin. Neurol., 2017, 30: 187–192. doi: 10.1097/WCO.0000000000000432.BoisonD.: New insights into the mechanism of the ketogenic diet. Curr. Opin. Neurol., 2017, 30: 187–192. doi: 10.1097/WCO.0000000000000432.540983228141738Open DOISearch in Google Scholar
Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G. et al: Mitochondrial Biogenesis in the Anticonvulsant Mechanism of the Ketogenic Diet. Ann. Neurol., 2006, 60: 223–235. doi: 10.1002/ana.20899.BoughK.J.WetheringtonJ.HasselB.PareJ.F.GawrylukJ.W.GreeneJ.G.: Mitochondrial Biogenesis in the Anticonvulsant Mechanism of the Ketogenic Diet. Ann. Neurol., 2006, 60: 223–235. doi: 10.1002/ana.20899.16807920Open DOISearch in Google Scholar
Bough K.J., Rho J.M.: Anitconvulsant Mechanism of the Ketogenic Diet. Epilepsia, 2007, 48: 43–58. doi: 10.1111/j.1528-1167.2007.00915.x.BoughK.J.RhoJ.M.: Anitconvulsant Mechanism of the Ketogenic Diet. Epilepsia, 2007, 48: 43–58. doi: 10.1111/j.1528-1167.2007.00915.x.17241207Open DOISearch in Google Scholar
Bruce S., Devlin A., Air L., Cook L.: Changes in quality of life as a result of ketogenic diet therapy: A new approach to assessment with the potential for positive therapeutic effects. Epilepsy Behav., 2017, 66: 100–104. doi: 10.1016/j.yebeh.2016.10.001.BruceS.DevlinA.AirL.CookL.: Changes in quality of life as a result of ketogenic diet therapy: A new approach to assessment with the potential for positive therapeutic effects. Epilepsy Behav., 2017, 66: 100–104. doi: 10.1016/j.yebeh.2016.10.001.28038385Open DOISearch in Google Scholar
Cai Q.Y., Zhou Z.J., Luo R., Gan J., Li S.P., Mu D.Z., Wan C.M.: Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J. Pediatr., 2017, 13: 528–536. doi: 10.1007/s12519-017-0053-2.CaiQ.Y.ZhouZ.J.LuoR.GanJ.LiS.P.MuD.Z.WanC.M.: Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J. Pediatr., 2017, 13: 528–536. doi: 10.1007/s12519-017-0053-2.28702868Open DOISearch in Google Scholar
Caraballo R.H.: Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia, 2011, 52 (Suppl. 2): 79–82. doi: 10.1111/j.1528-1167.2011.03009.x.CaraballoR.H.: Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia, 2011, 52 (Suppl. 2): 79–82. doi: 10.1111/j.1528-1167.2011.03009.x.21463287Open DOISearch in Google Scholar
Caraballo R.H., Cersósimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N.: Ketogenic diet in patients with Dravet syndrome. Epilepsia, 2005, 46: 1539–1544. doi: 10.1111/j.1528-1167.2005.05705.x.CaraballoR.H.CersósimoR.O.SakrD.CrestaA.EscobalN.FejermanN.: Ketogenic diet in patients with Dravet syndrome. Epilepsia, 2005, 46: 1539–1544. doi: 10.1111/j.1528-1167.2005.05705.x.16146451Open DOISearch in Google Scholar
Caraballo R.H., Cersósimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N.: Ketogenic diet in patients with myoclonicastatic epilepsy. Epileptic Disord., 2006, 8: 151–155.CaraballoR.H.CersósimoR.O.SakrD.CrestaA.EscobalN.FejermanN.: Ketogenic diet in patients with myoclonicastatic epilepsy. Epileptic Disord., 2006, 8: 151–155.Search in Google Scholar
Caraballo R.H., Fortini S., Fresler S., Armeno M., Ariela A., Cresta A. et al.: Ketogenic diet in patients with Lennox-Gastaut syndrome. Seizure, 2014, 23: 751–755. doi: 10.1016/j.seizure.2014.06.005.CaraballoR.H.FortiniS.FreslerS.ArmenoM.ArielaA.CrestaA.: Ketogenic diet in patients with Lennox-Gastaut syndrome. Seizure, 2014, 23: 751–755. doi: 10.1016/j.seizure.2014.06.005.25011392Open DOISearch in Google Scholar
Cervenka M.C., Henry B.J., Felton E.A., Patton K., Kossoff E.H.: Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges. Epilepsy Behav., 2016(a), 58: 61–68. doi: 10.1016/j.yebeh.2016.02.038.CervenkaM.C.HenryB.J.FeltonE.A.PattonK.KossoffE.H.: Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges. Epilepsy Behav., 2016(a), 58: 61–68. doi: 10.1016/j.yebeh.2016.02.038.27060389Open DOISearch in Google Scholar
Cervenka M.C., Henry-Barron B.J., Kossoff E.H.: Is there a role for diet monotherapy in adult epilepsy? Epilepsy Behav. Case Rep., 2016(b), 7: 6–9. doi: 10.1016/j.ebcr.2016.09.005.CervenkaM.C.Henry-BarronB.J.KossoffE.H.: Is there a role for diet monotherapy in adult epilepsy?Epilepsy Behav. Case Rep., 2016(b), 7: 6–9. doi: 10.1016/j.ebcr.2016.09.005.519806428053859Open DOISearch in Google Scholar
Cervenka M.C., Kossoff E.H.: Dietary treatment of intractable epilepsy. Continuum (Minneap Minn), 2013, 19 (3 Epilepsy): 756–766. doi: 10.1212/01.CON.0000431396.23852.56.CervenkaM.C.KossoffE.H.: Dietary treatment of intractable epilepsy. Continuum (Minneap Minn), 2013, 19 (3 Epilepsy): 756–766. doi: 10.1212/01.CON.0000431396.23852.56.23739109Open DOISearch in Google Scholar
Cervenka M.C., Patton K., Eloyan A., Henry B., Kossoff E.H.: The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr. Neurosci., 2016(c), 19: 131–137. doi: 10.1179/1476830514Y.0000000162.CervenkaM.C.PattonK.EloyanA.HenryB.KossoffE.H.: The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr. Neurosci., 2016(c), 19: 131–137. doi: 10.1179/1476830514Y.0000000162.25383724Open DOISearch in Google Scholar
Chorągiewicz T., Żarnowska I., Gąsior M., Żarnowski T.: Przeciwdrgawkowe i neuroprotekcyjne działanie diety ketogennej. Przegl. Lek., 2010, 67: 205–212.ChorągiewiczT.ŻarnowskaI.GąsiorM.ŻarnowskiT.: Przeciwdrgawkowe i neuroprotekcyjne działanie diety ketogennej. Przegl. Lek., 2010, 67: 205–212.Search in Google Scholar
Cross J.H., Auvin S., Falip M., Striano P., Arzimanoglou A.: Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations. Front. Neurol., 2017, 8: 505. doi: 10.3389/fneur.2017.00505.CrossJ.H.AuvinS.FalipM.StrianoP.ArzimanoglouA.: Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations. Front. Neurol., 2017, 8: 505. doi: 10.3389/fneur.2017.00505.564913629085326Open DOISearch in Google Scholar
Cross J.H.: New research with diets and epilepsy. J. Child. Neurol., 2013, 28: 970–974. doi: 10.1177/0883073813487593.CrossJ.H.: New research with diets and epilepsy. J. Child. Neurol., 2013, 28: 970–974. doi: 10.1177/0883073813487593.23680944Open DOISearch in Google Scholar
Curatolo P., Jóźwiak S., Nabbout R. on behalf of participants of the TSC Consensus Meeting for SEGA and Epilepsy Management.: Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur. J. Paediatr. Neurol., 2012, 16: 582–586. doi: 10.1016/j.ejpn.2012.05.004.CuratoloP.JóźwiakS.NabboutR. on behalf of participants of the TSC Consensus Meeting for SEGA and Epilepsy Management.: Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur. J. Paediatr. Neurol., 2012, 16: 582–586. doi: 10.1016/j.ejpn.2012.05.004.22695035Open DOISearch in Google Scholar
Danial N.N., Hartman A.L., Stafstrom C.E., Thio L.L.: How does the ketogenic diet work? Four potential mechanisms. J. Child. Neurol., 2013, 28: 1027–1033. doi: 10.1177/0883073813487598DanialN.N.HartmanA.L.StafstromC.E.ThioL.L.: How does the ketogenic diet work? Four potential mechanisms. J. Child. Neurol., 2013, 28: 1027–1033. doi: 10.1177/0883073813487598397199623670253Open DOISearch in Google Scholar
Dressler A., Haiden N., Trimmel-Schwahofer P., Benninger F., Samueli S., Gröppel G. et al: Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy. Epilepsia Open, 2018, 3: 30–39. doi: 10.1002/epi4.12084.DresslerA.HaidenN.Trimmel-SchwahoferP.BenningerF.SamueliS.GröppelG.: Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy. Epilepsia Open, 2018, 3: 30–39. doi: 10.1002/epi4.12084.583930629588985Open DOISearch in Google Scholar
Dressler A., Trimmel-Schwahofer P., Reithofer E., Gröppel G., Mühlebner A., Samueli S. et al: The ketogenic diet in infants – Advantages of early use. Epilepsy Res., 2015(a), 116: 53–58. doi: 10.1016/j.eplepsyres.2015.06.015.DresslerA.Trimmel-SchwahoferP.ReithoferE.GröppelG.MühlebnerA.SamueliS.: The ketogenic diet in infants – Advantages of early use. Epilepsy Res., 2015(a), 116: 53–58. doi: 10.1016/j.eplepsyres.2015.06.015.26354167Open DOISearch in Google Scholar
Dressler A., Trimmel-Schwahofer P., Reithofer E., Mühlebner A., Gröppel G., Reiter-Fink E. et al.: Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen. Epilepsy Res., 2015(b), 109: 81–89. doi: 10.1016/j.eplepsyres.2014.10.014.DresslerA.Trimmel-SchwahoferP.ReithoferE.MühlebnerA.GröppelG.Reiter-FinkE.: Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen. Epilepsy Res., 2015(b), 109: 81–89. doi: 10.1016/j.eplepsyres.2014.10.014.25524846Open DOISearch in Google Scholar
Dulac O., Takahashi T.: Status epilepticus. Handb. Clin. Neurol., 2013, 111: 681–689. doi: 10.1016/B978-0-444-528919.00070-1.DulacO.TakahashiT.: Status epilepticus. Handb. Clin. Neurol., 2013, 111: 681–689. doi: 10.1016/B978-0-444-528919.00070-1.Open DOISearch in Google Scholar
Elamin M., Ruskin D.N., Masino S.A., Sacchettti P.: Ketone-based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? Front. Mol. Neurosci., 2017, 10: 377. doi: 10.3389/fnmol.2017.00377.ElaminM.RuskinD.N.MasinoS.A.SacchetttiP.: Ketone-based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?Front. Mol. Neurosci., 2017, 10: 377. doi: 10.3389/fnmol.2017.00377.569448829184484Open DOISearch in Google Scholar
Elia M., Klepper J., Leiendecker B., Hartmann H.: Ketogenic diets in the treatment of epilepsy. Curr. Pharm. Des., 2017, 23: 5691–5701. doi: 10.2174/1381612823666170809101517.EliaM.KlepperJ.LeiendeckerB.HartmannH.: Ketogenic diets in the treatment of epilepsy. Curr. Pharm. Des., 2017, 23: 5691–5701. doi: 10.2174/1381612823666170809101517.28799513Open DOISearch in Google Scholar
El-Rashidy O.F., Nassar M.F., Abdel-Hamid I.A., Shatla R.H., Abdel-Hamid M.H., Gabr S.S. et al.: Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol. Scand., 2013, 128: 402–408. doi: 10.1111/ane.12137.El-RashidyO.F.NassarM.F.Abdel-HamidI.A.ShatlaR.H.Abdel-HamidM.H.GabrS.S.: Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol. Scand., 2013, 128: 402–408. doi: 10.1111/ane.12137.23679058Open DOISearch in Google Scholar
Eun S.H. Kang H.C., Kim D.W., Kim H.D.: Ketogenic diet for treatment of infantile spasms. Brain Dev., 2006, 28: 566–571. doi: 10.1016/j.braindev.2006.03.011.EunS.H.KangH.C.KimD.W.KimH.D.: Ketogenic diet for treatment of infantile spasms. Brain Dev., 2006, 28: 566–571. doi: 10.1016/j.braindev.2006.03.011.16697132Open DOISearch in Google Scholar
Farias-Moeller R., Bartolini L., Pasupuleti A., Cines R.D.B., Kao A., Carpenter J.L.: A practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus. Neurocrit Care, 2017, 26: 267–272. doi: 10.1007/s12028-016-0312-4.Farias-MoellerR.BartoliniL.PasupuletiA.CinesR.D.B.KaoA.CarpenterJ.L.: A practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus. Neurocrit Care, 2017, 26: 267–272. doi: 10.1007/s12028-016-0312-4.27553113Open DOISearch in Google Scholar
Fliciński J., Starczewska M., Steinborn B.: Wtórne niedobory i możliwości suplementacji L-karnityny w praktyce neurologa. Neurol. Dziec., 2016, 25: 29–38. doi: 10.20966/chn.2016.51.382.FlicińskiJ.StarczewskaM.SteinbornB.: Wtórne niedobory i możliwości suplementacji L-karnityny w praktyce neurologa. Neurol. Dziec., 2016, 25: 29–38. doi: 10.20966/chn.2016.51.382.Open DOISearch in Google Scholar
Freeman J.M., Vining E.P., Kossoff E.H., Pyzik P.L., Ye X., Goodman S.N.: A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 322–325. doi: 10.1111/j.1528-1167.2008.01740.x.FreemanJ.M.ViningE.P.KossoffE.H.PyzikP.L.YeX.GoodmanS.N.: A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 322–325. doi: 10.1111/j.1528-1167.2008.01740.x.18717710Open DOISearch in Google Scholar
Freeman J.M., Vining E.P., Pillas D.J., Pyzik P.L., Casey J.C., Kelly M.T.: The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics, 1998, 102: 1358–1363. doi: 10.1542/peds.102.6.1358.FreemanJ.M.ViningE.P.PillasD.J.PyzikP.L.CaseyJ.C.KellyM.T.: The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics, 1998, 102: 1358–1363. doi: 10.1542/peds.102.6.1358.9832569Open DOISearch in Google Scholar
French J.A., Koepp M., Naegelin Y., Vigevano F., Auvin S., Rho J.M. et al.: Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia, 2017 (Suppl. 58), 3: 69–82. doi: 10.1111/epi.13779.FrenchJ.A.KoeppM.NaegelinY.VigevanoF.AuvinS.RhoJ.M.: Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia, 2017 (Suppl. 58), 3: 69–82. doi: 10.1111/epi.13779.567908128675558Open DOISearch in Google Scholar
Gaspard N., Hirsch L.J., Sculier C., Loddenkemper T., van Baalen A., Lancrenon J. et al.: New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia, 2018, 59: 745–752. doi: 10.1111/epi.14022.GaspardN.HirschL.J.SculierC.LoddenkemperT.van BaalenA.LancrenonJ.: New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia, 2018, 59: 745–752. doi: 10.1111/epi.14022.29476535Open DOISearch in Google Scholar
Greco T., Glenn T.C., Hovda D.A., Prins M.L.: Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J. Cereb. Blood Flow Metab., 2016, 36: 1603–1613. doi: 10.1177/0271678X15610584.GrecoT.GlennT.C.HovdaD.A.PrinsM.L.: Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J. Cereb. Blood Flow Metab., 2016, 36: 1603–1613. doi: 10.1177/0271678X15610584.501251726661201Open DOISearch in Google Scholar
Groesbeck D.K., Bluml R.M., Kossoff E.H.: Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child. Neurol., 2006, 48: 978–981. doi: 10.1017/S0012162206002143.GroesbeckD.K.BlumlR.M.KossoffE.H.: Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child. Neurol., 2006, 48: 978–981. doi: 10.1017/S0012162206002143.17109786Open DOISearch in Google Scholar
Groomes L.B., Pyzik P.L., Turner Z., Dorward J.L., Goode V.H., Kossoff E.H.: Do Patients With Absence Epilepsy Respond to Ketogenic Diets? J. Child. Neurol., 2011, 26: 160–165. doi: 10.1177/0883073810376443.GroomesL.B.PyzikP.L.TurnerZ.DorwardJ.L.GoodeV.H.KossoffE.H.: Do Patients With Absence Epilepsy Respond to Ketogenic Diets?J. Child. Neurol., 2011, 26: 160–165. doi: 10.1177/0883073810376443.20647578Open DOISearch in Google Scholar
Hallböök T., Lundgren J., Rosén I.: Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia, 2007, 48: 59–65.HallböökT.LundgrenJ.RosénI.: Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia, 2007, 48: 59–65.10.1111/j.1528-1167.2006.00834.x17241208Search in Google Scholar
Hallböök T., Ji S., Maudsley S., Martin B.: The effects of the ketogenic diet on behavior and cognition. Epilepsy Res., 2012, 100: 304–309. doi: 10.1016/j.eplepsyres.2011.04.017.HallböökT.JiS.MaudsleyS.MartinB.: The effects of the ketogenic diet on behavior and cognition. Epilepsy Res., 2012, 100: 304–309. doi: 10.1016/j.eplepsyres.2011.04.017.411204021872440Open DOISearch in Google Scholar
Hartman A.L., Vining E.P.G: Clinical Aspects of the Ketogenic Diet. Epilepsia, 2007, 48: 31–42. doi: 10.1111/j.1528-1167.2007.00914.x.HartmanA.L.ViningE.P.G: Clinical Aspects of the Ketogenic Diet. Epilepsia, 2007, 48: 31–42. doi: 10.1111/j.1528-1167.2007.00914.x.17241206Open DOISearch in Google Scholar
Hemingway C., Freeman J.M., Pillas D.J., Pyzik P.L.: The ketogenic diet: a 3- to 6-year follow up of 150 children enrolled prospectively. Pediatrics, 2001, 108: 898–905.HemingwayC.FreemanJ.M.PillasD.J.PyzikP.L.: The ketogenic diet: a 3- to 6-year follow up of 150 children enrolled prospectively. Pediatrics, 2001, 108: 898–905.10.1542/peds.108.4.89811581442Search in Google Scholar
Henderson C.B., Filloux F.M., Alder S.C., Lyon J., Caplin D.A.: Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis. J. Child. Neurol., 2006, 21: 193–198.HendersonC.B.FillouxF.M.AlderS.C.LyonJ.CaplinD.A.: Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis. J. Child. Neurol., 2006, 21: 193–198.10.2310/7010.2006.0004416901419Search in Google Scholar
Heo G., Kim S.H., Chang M.J.: Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy. J. Clin. Pharm. Ther., 2017, 42: 758–764. doi: 10.1111/jcpt.12578.HeoG.KimS.H.ChangM.J.: Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy. J. Clin. Pharm. Ther., 2017, 42: 758–764. doi: 10.1111/jcpt.12578.28626875Open DOISearch in Google Scholar
Hong A.M., Turner Z., Hamdy R.F., Kossoff E.H.: Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia, 2010, 51: 1403–1407.HongA.M.TurnerZ.HamdyR.F.KossoffE.H.: Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia, 2010, 51: 1403–1407.10.1111/j.1528-1167.2010.02586.x20477843Search in Google Scholar
IJff D.M., Postulart D., Lambrechts D.A.J.E., Majoie M.H.J.M., de Kinderen R.J.A., Hendriksen J.G.M. et al.: Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav., 2016, 60: 153–157. doi: 10.1016/j.yebeh.2016.04.033.IJffD.M.PostulartD.LambrechtsD.A.J.E.MajoieM.H.J.M.de KinderenR.J.A.HendriksenJ.G.M.: Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav., 2016, 60: 153–157. doi: 10.1016/j.yebeh.2016.04.033.27206235Open DOISearch in Google Scholar
Jung D.E., Kang H.C., Kim H.D.: Long-term outcome of the ketogenic diet for intractable childhood epilepsy with focal malformation of cortical development. Pediatrics, 2008, 122: e330–e333. doi: 10.1542/peds.2008-0012.JungD.E.KangH.C.KimH.D.: Long-term outcome of the ketogenic diet for intractable childhood epilepsy with focal malformation of cortical development. Pediatrics, 2008, 122: e330–e333. doi: 10.1542/peds.2008-0012.18676519Open DOISearch in Google Scholar
Kang H.C., Chung D.E., Kim D.W., Kim H.D.: Early and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia, 2004, 45: 1116–1123. doi: 10.1111/j.0013-9580.2004.10004.x.KangH.C.ChungD.E.KimD.W.KimH.D.: Early and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia, 2004, 45: 1116–1123. doi: 10.1111/j.0013-9580.2004.10004.x.15329077Open DOISearch in Google Scholar
Kang H.C., Lee Y.J., Lee J.S., Eom S.J., You S.J., Kim H.D.: Comparison of short-versus long-term ketogenic diet for intractable infantile spasm. Epilepsia, 2011, 52: 781–787.KangH.C.LeeY.J.LeeJ.S.EomS.J.YouS.J.KimH.D.: Comparison of short-versus long-term ketogenic diet for intractable infantile spasm. Epilepsia, 2011, 52: 781–787.10.1111/j.1528-1167.2010.02940.x21269294Search in Google Scholar
Kang H.C., Kim Y.J., Kim D.W., Kim H.D.: Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia, 2005, 46: 272–279. doi: 10.1111/j.0013-9580.2005.48504.x.KangH.C.KimY.J.KimD.W.KimH.D.: Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia, 2005, 46: 272–279. doi: 10.1111/j.0013-9580.2005.48504.x.15679508Open DOISearch in Google Scholar
Kayyali H.R., Gustafson M., Myers T., Thompson L., Williams M., Abdelmoity A.: Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr. Neurol., 2014, 50: 224–227. doi: 10.1016/j.pediatrneurol.2013.11.021.KayyaliH.R.GustafsonM.MyersT.ThompsonL.WilliamsM.AbdelmoityA.: Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr. Neurol., 2014, 50: 224–227. doi: 10.1016/j.pediatrneurol.2013.11.021.24433856Open DOISearch in Google Scholar
Kayyali H.R., Luniova A., Abdelmoity A.: Ketogenic Diet decreases Emergency Room Visits and Hospitalizations Related to Epilepsy. Epilepsy Res. Treat., 2016: 5873208. doi: 10.1155/2016/5873208.KayyaliH.R.LuniovaA.AbdelmoityA.: Ketogenic Diet decreases Emergency Room Visits and Hospitalizations Related to Epilepsy. Epilepsy Res. Treat., 2016: 5873208. doi: 10.1155/2016/5873208.505626527752367Open DOISearch in Google Scholar
Keene D.L.: A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr. Neurol., 2006, 35: 1–5. doi: 10.1016/j.pediatrneurol.2006.01.005.KeeneD.L.: A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr. Neurol., 2006, 35: 1–5. doi: 10.1016/j.pediatrneurol.2006.01.005.16814077Open DOISearch in Google Scholar
Kessler S.K., Gallagher P.R., Shellhaas R.A., Clancy R.R., Bergqvist A.G.: Early EEG improvement after ketogenic diet initiation. Epilepsy Res., 2011, 94: 94–101. doi: 10.1016/j.eplepsyres.2011.01.012.KesslerS.K.GallagherP.R.ShellhaasR.A.ClancyR.R.BergqvistA.G.: Early EEG improvement after ketogenic diet initiation. Epilepsy Res., 2011, 94: 94–101. doi: 10.1016/j.eplepsyres.2011.01.012.306219021345653Open DOISearch in Google Scholar
Kilaru S., Bergqvist A.G.C.: Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia, 2007, 48: 1703–1707. doi: 10.1111/j.1528-1167.2007.01186.x.KilaruS.BergqvistA.G.C.: Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia, 2007, 48: 1703–1707. doi: 10.1111/j.1528-1167.2007.01186.x.17651420Open DOISearch in Google Scholar
Kim D.W., Kang H.C., Park J.C., Kim H.D.: Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics, 2004, 114: 1627–1630. doi: 10.1542/peds.2004-1001.KimD.W.KangH.C.ParkJ.C.KimH.D.: Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics, 2004, 114: 1627–1630. doi: 10.1542/peds.2004-1001.15574625Open DOISearch in Google Scholar
Kim J.A., Yoon J.R., Lee E.J., Lee J.S., Kim J.T., Kim H.D., Kang H.C.: Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia, 2016, 57: 51–58. doi: 10.1111/epi.13256.KimJ.A.YoonJ.R.LeeE.J.LeeJ.S.KimJ.T.KimH.D.KangH.C.: Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia, 2016, 57: 51–58. doi: 10.1111/epi.13256.26662710Open DOISearch in Google Scholar
de Kinderen R.J., Lambrechts D.A., Postulart D., Kessels A.G., Hendriksen J.G., Aldenkamp A.P. et al.: Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurol., 2011, 11: 10.de KinderenR.J.LambrechtsD.A.PostulartD.KesselsA.G.HendriksenJ.G.AldenkampA.P.: Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurol., 2011, 11: 10.10.1186/1471-2377-11-10303958021262002Search in Google Scholar
de Kinderen R.J., Lambrechts D.A., Wijnen B.F., Postulart D., Aldenkamp A.P., Majoie M.H., Evers S.M.: An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis. Epilepsia, 2016, 57: 41–50.de KinderenR.J.LambrechtsD.A.WijnenB.F.PostulartD.AldenkampA.P.MajoieM.H.EversS.M.: An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis. Epilepsia, 2016, 57: 41–50.10.1111/epi.1325426617284Search in Google Scholar
de Kinderen R.J., Postulart D., Aldenkamp A.P., Evers S.M., Lambrechts D.A., Louw A.J. et al.: Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. Epilepsy Res., 2015, 110: 119–131. doi: 10.1016/j.eplepsyres.2014.12.005.de KinderenR.J.PostulartD.AldenkampA.P.EversS.M.LambrechtsD.A.LouwA.J.: Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. Epilepsy Res., 2015, 110: 119–131. doi: 10.1016/j.eplepsyres.2014.12.005.25616464Open DOISearch in Google Scholar
Kinsman S.L., Vining E.P., Quaskey S.A., Mellits D., Freeman J.M.: Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia, 1992, 33: 1132–1136.KinsmanS.L.ViningE.P.QuaskeyS.A.MellitsD.FreemanJ.M.: Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia, 1992, 33: 1132–1136.10.1111/j.1528-1157.1992.tb01770.x1464275Search in Google Scholar
Klein P., Janousek J., Barber A., Weissberger R.: Ketogenic diet in adults with refractory epilepsy. Epilepsy Behav., 2010, 19: 575–579. doi: 10.1016/j.yebeh.2010.09.016.KleinP.JanousekJ.BarberA.WeissbergerR.: Ketogenic diet in adults with refractory epilepsy. Epilepsy Behav., 2010, 19: 575–579. doi: 10.1016/j.yebeh.2010.09.016.20937568Open DOISearch in Google Scholar
Klepper J., Leiendecker B., Bredhal R., Athanassopoulos S., Heinen, F., Gertsen E. et al: Introduction of a ketogenic diet in young infants. J. Inherit. Metab. Dis., 2002, 25: 449–460.KlepperJ.LeiendeckerB.BredhalR.AthanassopoulosS.Heinen,F.GertsenE.: Introduction of a ketogenic diet in young infants. J. Inherit. Metab. Dis., 2002, 25: 449–460.10.1023/A:1021238900470Search in Google Scholar
Kose E., Guzel O., Arslan N.: Analysis of hematological parameters in patients treated with ketogenic diet due to drug-resistant epilepsy. Neurol. Sci., 2018, 39: 85–89. doi: 10.1007/s10072-017-3152-x.KoseE.GuzelO.ArslanN.: Analysis of hematological parameters in patients treated with ketogenic diet due to drug-resistant epilepsy. Neurol. Sci., 2018, 39: 85–89. doi: 10.1007/s10072-017-3152-x.29038947Open DOISearch in Google Scholar
Kossoff E.H., Dorward J.L.: The Modified Atkins Diet. Epilepsia, 2008, 49 (Suppl. 8): 37–41. doi: 10.1111/j.1528-1167.2008.01831.x.KossoffE.H.DorwardJ.L.: The Modified Atkins Diet. Epilepsia, 2008, 49 (Suppl. 8): 37–41. doi: 10.1111/j.1528-1167.2008.01831.x.19049584Open DOISearch in Google Scholar
Kossoff E.H., Hedderick E.F., Turner Z., Freeman J.M.: A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia, 2008a, 49: 1504–1509. doi: 10.1111/j.1528-1167.2008.01606.x.KossoffE.H.HedderickE.F.TurnerZ.FreemanJ.M.: A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia, 2008a, 49: 1504–1509. doi: 10.1111/j.1528-1167.2008.01606.x.18410363Open DOISearch in Google Scholar
Kossoff E.H., Laux L.C., Blackford R., Morrison P.F., Pyzik P.L., Hamdy R.M. et al.: When do seizures usually improve with the ketogenic diet? Epilepsia, 2008b, 49: 329–333. doi: 10.1111/j.1528-1167.2007.01417.x.KossoffE.H.LauxL.C.BlackfordR.MorrisonP.F.PyzikP.L.HamdyR.M.: When do seizures usually improve with the ketogenic diet?Epilepsia, 2008b, 49: 329–333. doi: 10.1111/j.1528-1167.2007.01417.x.18028405Open DOISearch in Google Scholar
Kossoff E.H., Nabbout R.: Use of dietary therapy for status epilepticus. J. Child. Neurol., 2013, 28: 1049–1051. doi: 10.1177/0883073813487601.KossoffE.H.NabboutR.: Use of dietary therapy for status epilepticus. J. Child. Neurol., 2013, 28: 1049–1051. doi: 10.1177/0883073813487601.23640913Open DOISearch in Google Scholar
Kossoff E.H., Pyzik P.L., McGrogan J.R., Vining E.P., Freeman J.M.: Efficacy of the Ketogenic Diet for Infantile Spasms. Pediatrics, 2002, 109: 780–783. doi: 10.1542/peds.109.5.780.KossoffE.H.PyzikP.L.McGroganJ.R.ViningE.P.FreemanJ.M.: Efficacy of the Ketogenic Diet for Infantile Spasms. Pediatrics, 2002, 109: 780–783. doi: 10.1542/peds.109.5.780.11986436Open DOISearch in Google Scholar
Kossoff E.H., Thiele E.A., Pfeifer H.H., McGrogan J.R., Freeman J.M.: Tuberous sclerosis complex and the ketogenic diet. Epilepsia, 2005, 46: 1684–1686. doi: 10.1111/j.1528-1167.2005.00266.x.KossoffE.H.ThieleE.A.PfeiferH.H.McGroganJ.R.FreemanJ.M.: Tuberous sclerosis complex and the ketogenic diet. Epilepsia, 2005, 46: 1684–1686. doi: 10.1111/j.1528-1167.2005.00266.x.16190943Open DOISearch in Google Scholar
Kossoff E.H., Turner Z., Bluml R.M., Pyzik P.L., Vining E.P.G.: A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav., 2007, 10: 432–436. doi: 10.1016/j.yebeh.2007.01.012.KossoffE.H.TurnerZ.BlumlR.M.PyzikP.L.ViningE.P.G.: A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav., 2007, 10: 432–436. doi: 10.1016/j.yebeh.2007.01.012.17324628Open DOISearch in Google Scholar
Kossoff E.H., Wang H.S.: Dietary therapies for epilepsy. Biomed. J., 2013, 36: 2–8. doi: 10.4103/2319-4170.107152.KossoffE.H.WangH.S.: Dietary therapies for epilepsy. Biomed. J., 2013, 36: 2–8. doi: 10.4103/2319-4170.107152.23515147Open DOISearch in Google Scholar
Kossoff E.H., Zupec-Kania B.A., Amark P.E., Ballaban-Gil K.R., Bergqvist C.A.G., Blackford R. et al.: Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia, 2009a, 50: 304–317. doi: 10.1111/j.1528-1167.2008.01765.x.KossoffE.H.Zupec-KaniaB.A.AmarkP.E.Ballaban-GilK.R.BergqvistC.A.G.BlackfordR.: Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia, 2009a, 50: 304–317. doi: 10.1111/j.1528-1167.2008.01765.x.18823325Open DOISearch in Google Scholar
Kossoff E.H., Zupec-Kania B.A., Rho J.M.: Ketogenic Diets: An Update for Child Neurologists. J. Child. Neurol., 2009b, 24: 979–988. doi: 10.1177/0883073809337162.KossoffE.H.Zupec-KaniaB.A.RhoJ.M.: Ketogenic Diets: An Update for Child Neurologists. J. Child. Neurol., 2009b, 24: 979–988. doi: 10.1177/0883073809337162.19535814Open DOISearch in Google Scholar
Kramer U., Chi C.S., Lin K.L., Specchio N., Sahin M., Olson H. et al.: Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia, 2011, 52: 1956–1965. doi: 10.1111/j.1528-1167.2011.03250.x.KramerU.ChiC.S.LinK.L.SpecchioN.SahinM.OlsonH.: Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia, 2011, 52: 1956–1965. doi: 10.1111/j.1528-1167.2011.03250.x.21883180Open DOISearch in Google Scholar
Kwan P., Arzimanoglou A., Berg A.T., Brodie M. J., Hauser A.W., Mathern G. et al: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010, 51: 1069–1077. doi: 10.1111/j.1528-1167.2009.02397.x.KwanP.ArzimanoglouA.BergA.T.BrodieM. J.HauserA.W.MathernG.: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010, 51: 1069–1077. doi: 10.1111/j.1528-1167.2009.02397.x.19889013Open DOISearch in Google Scholar
Lambrechts D.A., de Kinderen R.J., Vles J.S., de Louw A.J., Aldenkamp A.P., Majoie H.J.: A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol. Scand., 2017, 135: 231–239. doi: 10.1111/ane.12592.LambrechtsD.A.de KinderenR.J.VlesJ.S.de LouwA.J.AldenkampA.P.MajoieH.J.: A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol. Scand., 2017, 135: 231–239. doi: 10.1111/ane.12592.27027847Open DOISearch in Google Scholar
Lee J., Lee J.H., Yu H.J., Lee M.: Prognostic factors of infantile spasms: role of treatment options including a ketogenic diet. Brain Dev., 2013, 35: 821–826. doi: 10.1016/j.braindev.2013.06.014.LeeJ.LeeJ.H.YuH.J.LeeM.: Prognostic factors of infantile spasms: role of treatment options including a ketogenic diet. Brain Dev., 2013, 35: 821–826. doi: 10.1016/j.braindev.2013.06.014.23856457Open DOISearch in Google Scholar
Lee M.: The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disorders. Korean J. Pediatr., 2012, 55: 316–321. doi: 10.3345/kjp.2012.55.9.316.LeeM.: The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disorders. Korean J. Pediatr., 2012, 55: 316–321. doi: 10.3345/kjp.2012.55.9.316.345457323049588Open DOISearch in Google Scholar
Lefevre F., Aronson N.: Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics, 2000, 105: E46.LefevreF.AronsonN.: Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics, 2000, 105: E46.10.1542/peds.105.4.e4610742367Search in Google Scholar
Lemmon M.E., Terao N.N., Ng Y.T., Reisig W., Rubenstein J.E., Kossoff E.H.: Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature. Dev. Med. Child. Neurol., 2012, 54: 464–468. doi: 10.1111/j.1469-8749.2012.04233.x.LemmonM.E.TeraoN.N.NgY.T.ReisigW.RubensteinJ.E.KossoffE.H.: Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature. Dev. Med. Child. Neurol., 2012, 54: 464–468. doi: 10.1111/j.1469-8749.2012.04233.x.22443637Open DOISearch in Google Scholar
Levy R., Cooper P.: Ketogenic diet for epilepsy. Cochrane Database Syst. Rev., 2003, 3: CD001903. doi: 10.1002/14651858.CD001903.LevyR.CooperP.: Ketogenic diet for epilepsy. Cochrane Database Syst. Rev., 2003, 3: CD001903. doi: 10.1002/14651858.CD001903.12917915Open DOISearch in Google Scholar
Li B., Tong L., Jia G., Sun R.: Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy. Exp. Ther. Med., 2013a, 5: 611–615. doi: 10.3892/etm.2012.823.LiB.TongL.JiaG.SunR.: Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy. Exp. Ther. Med., 2013a, 5: 611–615. doi: 10.3892/etm.2012.823.357011723404539Open DOISearch in Google Scholar
Li H.F., Zou Y., Ding G.: Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis. Iran J. Pediatr., 2013b, 23: 613–620.LiH.F.ZouY.DingG.: Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis. Iran J. Pediatr., 2013b, 23: 613–620.Search in Google Scholar
Lin A., Turner Z., Doerrer S.C., Stanfield A., Kossoff E.H.: Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. Pediatr. Neuro., 2017, 68: 35–39. doi: 10.1016/j.pediatrneurol.2017.01.007.LinA.TurnerZ.DoerrerS.C.StanfieldA.KossoffE.H.: Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. Pediatr. Neuro., 2017, 68: 35–39. doi: 10.1016/j.pediatrneurol.2017.01.007.28188074Open DOISearch in Google Scholar
Luat A.F., Coyle L., Kamat D.: The Ketogenic Diet: A Practical Guide for Pediatricians. Pediatr. Ann., 2016, 45: e446-e450. doi: 10.3928/19382359-20161109-01.LuatA.F.CoyleL.KamatD.: The Ketogenic Diet: A Practical Guide for Pediatricians. Pediatr. Ann., 2016, 45: e446-e450. doi: 10.3928/19382359-20161109-01.27975114Open DOISearch in Google Scholar
Lyczkowski D.A., Pfeifer H.H., Ghosh S., Thiele E.A.: Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia, 2005, 46: 1533–1538. doi: 10.1111/j.1528-1167.2005.22705.x.LyczkowskiD.A.PfeiferH.H.GhoshS.ThieleE.A.: Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia, 2005, 46: 1533–1538. doi: 10.1111/j.1528-1167.2005.22705.x.16146450Open DOISearch in Google Scholar
Maalouf M., Rho J.M., Mattson M.P.: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev., 2009, 59: 293–315. doi: 10.1016/j.brainresrev.2008.09.002.MaaloufM.RhoJ.M.MattsonM.P.: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev., 2009, 59: 293–315. doi: 10.1016/j.brainresrev.2008.09.002.264968218845187Open DOISearch in Google Scholar
Martin K., Jackson C.F., Levy R.G., Cooper P.N.: Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev., 2016, 2:CD001903. doi: 10.1002/14651858.CD001903.pub3.MartinK.JacksonC.F.LevyR.G.CooperP.N.: Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev., 2016, 2:CD001903. doi: 10.1002/14651858.CD001903.pub3.26859528Open DOISearch in Google Scholar
Martin-McGill K.J., Jenkinson M.D., Tudur Smith C., Marson A.G.: The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service. Seizure, 2017, 52: 1–6. doi: 10.1016/j.seizure.2017.08.013.Martin-McGillK.J.JenkinsonM.D.Tudur SmithC.MarsonA.G.: The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service. Seizure, 2017, 52: 1–6. doi: 10.1016/j.seizure.2017.08.013.28915401Open DOISearch in Google Scholar
Masino S.A., Rho J.M.: Mechanisms of Ketogenic Diet Action. In: J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (eds.), SourceJasper’s Basic Mechanisms of the Epilepsies [Internet]. 4th ed., Bethesda (MD): National Center for Biotechnology Information (US), 2012.MasinoS.A.RhoJ.M.: Mechanisms of Ketogenic Diet Action. In: J.L.NoebelsM.AvoliM.A.RogawskiR.W.OlsenA.V.Delgado-Escueta (eds.), SourceJasper’s Basic Mechanisms of the Epilepsies [Internet]. 4th ed., Bethesda (MD): National Center for Biotechnology Information (US), 2012.Search in Google Scholar
Mastrangelo M.: Lennox-Gastaut Syndrome: A State of the Art Review. Neuropediatrics, 2017, 48: 143–151. doi: 10.1055/s-0037-1601324.MastrangeloM.: Lennox-Gastaut Syndrome: A State of the Art Review. Neuropediatrics, 2017, 48: 143–151. doi: 10.1055/s-0037-1601324.28346953Open DOISearch in Google Scholar
McArtney R., Bailey A., Champion H.: What is a ketogenic diet and how does it affect the use of medicines? Arch. Dis. Child. Educ. Pract. Ed., 2017, 102: 194–199. doi: 10.1136/archdischild-2014-307000.McArtneyR.BaileyA.ChampionH.: What is a ketogenic diet and how does it affect the use of medicines? Arch. Dis. Child. Educ. Pract. Ed., 2017, 102: 194–199. doi: 10.1136/archdischild-2014-307000.27469127Open DOISearch in Google Scholar
McDaniel S.S., Rensing N.R., Thio L.L., Yamada K.A., Wong M.: The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia, 2011, 52: e7–e11. doi: 10.1111/j.1528-1167.2011.02981.McDanielS.S.RensingN.R.ThioL.L.YamadaK.A.WongM.: The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia, 2011, 52: e7–e11. doi: 10.1111/j.1528-1167.2011.02981.Open DOISearch in Google Scholar
McNally M.A., Pyzik P.L., Rubenstein J.E., Hamdy R.F., Kossoff E.H.: Empiric use of potassium citrate reduces kidney stone incidence with the ketogenic diet. Pediatrics, 2009, 124: e300–e304. doi: 10.1542/peds.2009-0217.McNallyM.A.PyzikP.L.RubensteinJ.E.HamdyR.F.KossoffE.H.: Empiric use of potassium citrate reduces kidney stone incidence with the ketogenic diet. Pediatrics, 2009, 124: e300–e304. doi: 10.1542/peds.2009-0217.559001019596731Open DOISearch in Google Scholar
Mc Tague A., Cross J.H.: Treatment of Epileptic Encephalopathies. CNS Drugs, 2013, 27: 175–184. doi: 10.1007/s40263-013-0041-6.Mc TagueA.CrossJ.H.: Treatment of Epileptic Encephalopathies. CNS Drugs, 2013, 27: 175–184. doi: 10.1007/s40263-013-0041-6.23397290Open DOISearch in Google Scholar
Mohanraj R., Brodie M.J.: Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol., 2006, 13: 277–282. doi: 10.1111/j.1468-1331.2006.01215.x.MohanrajR.BrodieM.J.: Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol., 2006, 13: 277–282. doi: 10.1111/j.1468-1331.2006.01215.x.16618346Open DOISearch in Google Scholar
Moriyama K., Watanabe M., Yamada Y., Shiihara T.: Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr. Neurol., 2015, 52: 526–528. doi: 10.1016/j.pediatrneurol.2015.01.009.MoriyamaK.WatanabeM.YamadaY.ShiiharaT.: Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr. Neurol., 2015, 52: 526–528. doi: 10.1016/j.pediatrneurol.2015.01.009.25724370Open DOISearch in Google Scholar
Morrison P.F., Pyzik P.L., Hamdy R., Hartman A.L., Kossoff E.H.: The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 1999–2001. doi: 10.1111/j.1528-1167.2009.02053.x.MorrisonP.F.PyzikP.L.HamdyR.HartmanA.L.KossoffE.H.: The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 1999–2001. doi: 10.1111/j.1528-1167.2009.02053.x.19389152Open DOISearch in Google Scholar
Mullen S.A., Marini C., Suls A., Mei D., Della Giustina E., Buti D. et al.: Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol., 2011, 68: 1152–1155. doi:10.1001/archneurol.2011.102.MullenS.A.MariniC.SulsA.MeiD.Della GiustinaE.ButiD.: Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol., 2011, 68: 1152–1155. doi:10.1001/archneurol.2011.102.21555602Open DOISearch in Google Scholar
Nabbout R., Camfield C.S., Andrade D.M., Arzimanoglou A., Chiron C., Cramer J.A. et al.: Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav., 2017, 69: 153–160. doi: 10.1016/j.yebeh.2016.11.008.NabboutR.CamfieldC.S.AndradeD.M.ArzimanoglouA.ChironC.CramerJ.A.: Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav., 2017, 69: 153–160. doi: 10.1016/j.yebeh.2016.11.008.28188045Open DOISearch in Google Scholar
Nabbout R., Copioli C., Chipaux M., Chemaly N., Desguerre I., Dulac O., Chiron C.: Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia, 2011, 52: e54–e57. doi: 10.1111/j.1528-1167.2011.03107.x.NabboutR.CopioliC.ChipauxM.ChemalyN.DesguerreI.DulacO.ChironC.: Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia, 2011, 52: e54–e57. doi: 10.1111/j.1528-1167.2011.03107.x.Open DOISearch in Google Scholar
Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V. et al: Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia, 2010, 51: 2033–2037. doi: 10.1111/j.1528-1167.2010.02703.x.NabboutR.MazzucaM.HubertP.PeudennierS.AllaireC.FlurinV.: Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia, 2010, 51: 2033–2037. doi: 10.1111/j.1528-1167.2010.02703.x.Open DOISearch in Google Scholar
Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G. et al: The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol., 2008, 7: 500–506. doi: 10.1016/S1474-4422(08)70092-9.NealE.G.ChaffeH.SchwartzR.H.LawsonM.S.EdwardsN.FitzsimmonsG.: The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol., 2008, 7: 500–506. doi: 10.1016/S1474-4422(08)70092-9.Open DOISearch in Google Scholar
Newell C., Bomhof M.R., Reimer R.A., Hittel D.S., Rho J.M., Shearer J.: Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol. Autism, 2016, 7: 37. doi: 10.1186/s13229-016-0099-3.NewellC.BomhofM.R.ReimerR.A.HittelD.S.RhoJ.M.ShearerJ.: Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol. Autism, 2016, 7: 37. doi: 10.1186/s13229-016-0099-3.500954127594980Open DOISearch in Google Scholar
Nizamuddin J., Turner Z., Rubenstein J.E., Pyzik P.L., Kossoff E.H.: Management and Risk Factors for Dyslipidemia With the Ketogenic Diet. J. Child. Neurol., 2008, 23: 758–761. doi: 10.1177/0883073808318061.NizamuddinJ.TurnerZ.RubensteinJ.E.PyzikP.L.KossoffE.H.: Management and Risk Factors for Dyslipidemia With the Ketogenic Diet. J. Child. Neurol., 2008, 23: 758–761. doi: 10.1177/0883073808318061.18658075Open DOISearch in Google Scholar
Nunes V.D., Sawyer L., Neilson J., Sarri G., Cross J.H.: Diagnosis and management of epilepsies in adults and children: summary of updated NICE guidance. BMJ, 2012, 344: e281. doi: 10.1136/bmj.e281.NunesV.D.SawyerL.NeilsonJ.SarriG.CrossJ.H.: Diagnosis and management of epilepsies in adults and children: summary of updated NICE guidance. BMJ, 2012, 344: e281. doi: 10.1136/bmj.e281.22282528Open DOISearch in Google Scholar
Nordli D.R. Jr, Kuroda M.M., Carroll J., Koenigsberger D.Y., Hirsch L.J., Bruner H.J. et al.: Experience with the ketogenic diet in infants. Pediatrics, 2001, 108: 129–133.NordliD.R.JrKurodaM.M.CarrollJ.KoenigsbergerD.Y.HirschL.J.BrunerH.J.: Experience with the ketogenic diet in infants. Pediatrics, 2001, 108: 129–133.10.1542/peds.108.1.12911433065Search in Google Scholar
Ozdemir R., Kucuk M., Guzel O., Karadeniz C., Yilmaz U., Mese T.: Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy?: One-year follow-up results. Brain Dev., 2016, 38: 842–847. doi: 10.1016/j.braindev.2016.03.009.OzdemirR.KucukM.GuzelO.KaradenizC.YilmazU.MeseT.: Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy?: One-year follow-up results. Brain Dev., 2016, 38: 842–847. doi: 10.1016/j.braindev.2016.03.009.27066714Open DOISearch in Google Scholar
Palmer S., Towne M.C., Pearl P.L., Pelletier R.C., Genetti C.A., Shi J. et al: SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures. Pediatr. Neurol., 2016, 64: 77–79. doi: 10.1016/j.pediatrneurol.2016.07.012.PalmerS.TowneM.C.PearlP.L.PelletierR.C.GenettiC.A.ShiJ.: SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures. Pediatr. Neurol., 2016, 64: 77–79. doi: 10.1016/j.pediatrneurol.2016.07.012.522355027600546Open DOISearch in Google Scholar
Park S., Lee E.J, Eom S., Kang H.C., Lee J.S., Kim H.D.: Ketogenic Diet for the management of Epilepsy Associated with Tuberous Sclerosis Complex in Children. J. Epilepsy Res., 2017, 7: 45–49. doi: 10.14581/jer.17008.ParkS.LeeE.JEomS.KangH.C.LeeJ.S.KimH.D.: Ketogenic Diet for the management of Epilepsy Associated with Tuberous Sclerosis Complex in Children. J. Epilepsy Res., 2017, 7: 45–49. doi: 10.14581/jer.17008.554069028775955Open DOISearch in Google Scholar
Pascal L., Caraballo R.H., De Giorgis V., Reyes J.G., Macasaet J.A., Masnada S. et al.: Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two-centre experience. Seizure, 2018, 57: 34–37. doi: 10.1016/j.seizure.2018.03.005.PascalL.CaraballoR.H.De GiorgisV.ReyesJ.G.MacasaetJ.A.MasnadaS.: Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two-centre experience. Seizure, 2018, 57: 34–37. doi: 10.1016/j.seizure.2018.03.005.29554640Open DOISearch in Google Scholar
Patel A., Pyzik P.L., Turner Z., Rubenstein J.E., Kossoff E.H.: Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia, 2010, 51: 1277–1282. doi: 10.1111/j.1528-1167.2009.02488.x.PatelA.PyzikP.L.TurnerZ.RubensteinJ.E.KossoffE.H.: Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia, 2010, 51: 1277–1282. doi: 10.1111/j.1528-1167.2009.02488.x.20132287Open DOISearch in Google Scholar
Paul E., Conant K.D. Dunne I.E., Pfeifer H.H., Lyczkowski D.A., Linshaw M.A., Thiele E.A.: Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res., 2010, 90: 151–156. doi: 10.1016/j.eplepsyres.2010.04.005.PaulE.ConantK.D.DunneI.E.PfeiferH.H.LyczkowskiD.A.LinshawM.A.ThieleE.A.: Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res., 2010, 90: 151–156. doi: 10.1016/j.eplepsyres.2010.04.005.306340820466520Open DOISearch in Google Scholar
Pires M.E., Ilea A., Bourel E., Bellavoine V., Merdariu D., Berquin P., Auvin S.: Ketogenic diet for infantile spasms refractory to first-line treatments: an open prospective study. Epilepsy Res., 2013, 105: 189–194. doi: 10.1016/j.eplepsyres.2012.11.009.PiresM.E.IleaA.BourelE.BellavoineV.MerdariuD.BerquinP.AuvinS.: Ketogenic diet for infantile spasms refractory to first-line treatments: an open prospective study. Epilepsy Res., 2013, 105: 189–194. doi: 10.1016/j.eplepsyres.2012.11.009.23357723Open DOISearch in Google Scholar
Prasad C., Rupar T., Prasad A.N.: Pyruvate dehydrogenase deficiency and epilepsy. Brain Dev., 2011, 33: 856–865. doi: 10.1016/j.braindev.2011.08.003.PrasadC.RuparT.PrasadA.N.: Pyruvate dehydrogenase deficiency and epilepsy. Brain Dev., 2011, 33: 856–865. doi: 10.1016/j.braindev.2011.08.003.21908116Open DOISearch in Google Scholar
Prezioso G., Carlone G., Zaccara G., Verrotti A.: Efficacy of ketogenic diet for infantile spasms: A systematic review. Acta Neurol. Scand., 2018, 137: 4–11. doi: 10.1111/ane.12830.PreziosoG.CarloneG.ZaccaraG.VerrottiA.: Efficacy of ketogenic diet for infantile spasms: A systematic review. Acta Neurol. Scand., 2018, 137: 4–11. doi: 10.1111/ane.12830.28875525Open DOISearch in Google Scholar
Pulsifer M.B., Gordon J.M., Brandt J., Vining E.P., Freeman J.M.: Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev. Med. Child. Neurol., 2001, 43: 301–306.PulsiferM.B.GordonJ.M.BrandtJ.ViningE.P.FreemanJ.M.: Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev. Med. Child. Neurol., 2001, 43: 301–306.10.1017/S0012162201000573Search in Google Scholar
Raju K.N., Gulati S., Kabra M., Agarwala A., Sharma S., Pandey R.M., Kalra V.: Efficacy of 4:1 (classic) versus 2,5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res., 2011, 96: 96–100. doi:10.1016/j.eplepsyres.2011.05.005.RajuK.N.GulatiS.KabraM.AgarwalaA.SharmaS.PandeyR.M.KalraV.: Efficacy of 4:1 (classic) versus 2,5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res., 2011, 96: 96–100. doi:10.1016/j.eplepsyres.2011.05.005.21621394Open DOISearch in Google Scholar
Rezaei S., Abdurahman A.A., Saghazadeh A., Badv R.S., Mahmoudi M.: Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescent with epilepsy: A systemic revive and meta-analysis. Nutr. Neurosci., 2017, 25:1–18. doi: 10.1080/1028415X.2017.1387721.RezaeiS.AbdurahmanA.A.SaghazadehA.BadvR.S.MahmoudiM.: Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescent with epilepsy: A systemic revive and meta-analysis. Nutr. Neurosci., 2017, 25:1–18. doi: 10.1080/1028415X.2017.1387721.29069983Open DOISearch in Google Scholar
Rho J.M., Stafstrom C.E.: The ketogenic diet: What has science taught us? Epilepsy Res., 2012, 100: 210–217. doi: 10.1016/j.eplepsyres.2011.05.021.RhoJ.M.StafstromC.E.: The ketogenic diet: What has science taught us?Epilepsy Res., 2012, 100: 210–217. doi: 10.1016/j.eplepsyres.2011.05.021.21856126Open DOISearch in Google Scholar
Rogawski M.A., Löscher W., Rho J.M.: Mechanisms of Action of Antiseizure Drugs and Ketogenic Diet. Cold Spring Harb. Perspect Med., 2016, 6. pii: a022780. doi: 10.1101/cshperspect.a022780.RogawskiM.A.LöscherW.RhoJ.M.: Mechanisms of Action of Antiseizure Drugs and Ketogenic Diet. Cold Spring Harb. Perspect Med., 2016, 6. pii: a022780. doi: 10.1101/cshperspect.a022780.485279726801895Open DOISearch in Google Scholar
Sampaio L.P.B., Takakura C., Manreza M.L.G.: The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. Neuropsiquiatr., 2017, 75: 234–237. doi: 10.1590/0004-282X20170028.SampaioL.P.B.TakakuraC.ManrezaM.L.G.: The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. Neuropsiquiatr., 2017, 75: 234–237. doi: 10.1590/0004-282X20170028.28489143Open DOISearch in Google Scholar
Schoeler N.E., Cross J.H.: Ketogenic dietary therapies in adults with epilepsy: a practical guide. Pract. Neurol., 2016, 16: 208–214. doi: 10.1136/practneurol-2015-001288.SchoelerN.E.CrossJ.H.: Ketogenic dietary therapies in adults with epilepsy: a practical guide. Pract. Neurol., 2016, 16: 208–214. doi: 10.1136/practneurol-2015-001288.26908897Open DOISearch in Google Scholar
Seo J.H., Lee Y.M., Lee J.S., Kang H.C., Kim H.D.: Efficacy and tolerability of the ketogenic diet according to lipid: nonlipid ratios-comparison of 3:1 with 4 :1 diet. Epilepsia, 2007, 48: 801–805. doi: 10.1111/j.1528-1167.2007.01025.x.SeoJ.H.LeeY.M.LeeJ.S.KangH.C.KimH.D.: Efficacy and tolerability of the ketogenic diet according to lipid: nonlipid ratios-comparison of 3:1 with 4 :1 diet. Epilepsia, 2007, 48: 801–805. doi: 10.1111/j.1528-1167.2007.01025.x.17386059Open DOISearch in Google Scholar
Sharma S., Jain P.: The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann. Indian Acad. Neurol., 2014, 17: 253–258. doi: 10.4103/0972-2327.138471.SharmaS.JainP.: The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann. Indian Acad. Neurol., 2014, 17: 253–258. doi: 10.4103/0972-2327.138471.416200825221391Open DOISearch in Google Scholar
Sharma S., Jain P., Gulati S., Sankhyan N., Agarwala A.: Use of the modified Atkins diet in Lennox Gastaut syndrome. J. Child Neurol., 2015, 30: 576–579. doi: 10.1177/0883073814527162.SharmaS.JainP.GulatiS.SankhyanN.AgarwalaA.: Use of the modified Atkins diet in Lennox Gastaut syndrome. J. Child Neurol., 2015, 30: 576–579. doi: 10.1177/0883073814527162.24659735Open DOISearch in Google Scholar
Sharma S., Sankhyan N., Gulati S., Agarwala A.: Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomised controlled trial. Epilepsia, 2013, 54: 481–486. doi: 10.1111/epi.12069.SharmaS.SankhyanN.GulatiS.AgarwalaA.: Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomised controlled trial. Epilepsia, 2013, 54: 481–486. doi: 10.1111/epi.12069.23294191Open DOISearch in Google Scholar
Sofou K., Dahlin M., Hallböök T., Lindefeldt M., Viggedal G., Darin N.: Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J. Inherit. Metab. Dis., 2017, 40: 237–245. doi:10.1007/s10545-016-0011-5.SofouK.DahlinM.HallböökT.LindefeldtM.ViggedalG.DarinN.: Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J. Inherit. Metab. Dis., 2017, 40: 237–245. doi:10.1007/s10545-016-0011-5.530643028101805Open DOISearch in Google Scholar
Spilioti M., Pavlou E., Gogou M., Katsanika I., Papadopoulou-Alataki E., Grafakou O. et al.: Valproate effect on ketosis in children under ketogenic diet. Eur. J. Paediatr. Neurol., 2016, 20: 555–559. doi: 10.1016/j.ejpn.2016.04.003.SpiliotiM.PavlouE.GogouM.KatsanikaI.Papadopoulou-AlatakiE.GrafakouO.: Valproate effect on ketosis in children under ketogenic diet. Eur. J. Paediatr. Neurol., 2016, 20: 555–559. doi: 10.1016/j.ejpn.2016.04.003.27117552Open DOISearch in Google Scholar
Stafstrom C.E., Rho J.M.: The Ketogenic Diet as a Treatment Paradigm for diverse Neurological Disorders. Front. Pharmacol., 2012, 3: 59. doi: 10.3389/fphar.2012.00059.StafstromC.E.RhoJ.M.: The Ketogenic Diet as a Treatment Paradigm for diverse Neurological Disorders. Front. Pharmacol., 2012, 3: 59. doi: 10.3389/fphar.2012.00059.332147122509165Open DOISearch in Google Scholar
Steinborn B., Mazurkiewicz-Bełdzińska M., Winczewska-Wiktor A.: Padaczka i drgawki w różnych okresach życia dziecka. In: B. Steinborn: Neurologia Wieku Rozwojowego, PZWL, Warszawa 2017, 311–560.SteinbornB.Mazurkiewicz-BełdzińskaM.Winczewska-WiktorA.: Padaczka i drgawki w różnych okresach życia dziecka. In: B.Steinborn: Neurologia Wieku Rozwojowego, PZWL, Warszawa2017, 311–560.Search in Google Scholar
Stenger E., Schaeffer M., Cances C., Motte J., Auvin S., Ville D. et al.: Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study. Epilepsy Res., 2017, 131: 64–69. doi: 10.1016/j.eplepsyres.2017.02.005.StengerE.SchaefferM.CancesC.MotteJ.AuvinS.VilleD.: Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study. Epilepsy Res., 2017, 131: 64–69. doi: 10.1016/j.eplepsyres.2017.02.005.28273610Open DOISearch in Google Scholar
Stevens C.E., Turner Z., Kossoff E.H.: Hepatic Dysfunction as a Complication of Combined Valproate and Ketogenic Diet. Pediatr. Neurol., 2016, 54: 82–84. doi: 10.1016/j.pediatrneurol.2015.10.006.StevensC.E.TurnerZ.KossoffE.H.: Hepatic Dysfunction as a Complication of Combined Valproate and Ketogenic Diet. Pediatr. Neurol., 2016, 54: 82–84. doi: 10.1016/j.pediatrneurol.2015.10.006.26706483Open DOISearch in Google Scholar
Strzelczyk A., Reif P.S., Bauer S., Belke M., Oertel W.H., Knake S., Rosenow F.: Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure, 2013, 22: 581–583. doi: 10.1016/j.seizure.2013.03.007.StrzelczykA.ReifP.S.BauerS.BelkeM.OertelW.H.KnakeS.RosenowF.: Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure, 2013, 22: 581–583. doi: 10.1016/j.seizure.2013.03.007.23597842Open DOISearch in Google Scholar
Takeoka M., Riviello J.J. Jr, Pfeifer H., Thiele E.A.: Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia, 2002, 43: 1072–1075.TakeokaM.RivielloJ.J.JrPfeiferH.ThieleE.A.: Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia, 2002, 43: 1072–1075.10.1046/j.1528-1157.2002.00602.x12199733Search in Google Scholar
Thammongkol S., Vears D.F., Bicknell-Royle J., Nation J., Draffin K., Stewart K.G. et al.: Efficacy of the ketogenic diet: which epilepsies respond? Epilepsia, 2012, 53: e55–e59. doi: 10.1111/j.1528-1167.2011.03394.x.ThammongkolS.VearsD.F.Bicknell-RoyleJ.NationJ.DraffinK.StewartK.G.: Efficacy of the ketogenic diet: which epilepsies respond?Epilepsia, 2012, 53: e55–e59. doi: 10.1111/j.1528-1167.2011.03394.x.22310062Open DOISearch in Google Scholar
Thiele E.A.: Implications of dietary therapy into the 21st century: conclusion to special issue. J. Child. Neurol., 2013, 28: 1054–1055. doi: 10.1177/0883073813488827.ThieleE.A.: Implications of dietary therapy into the 21st century: conclusion to special issue. J. Child. Neurol., 2013, 28: 1054–1055. doi: 10.1177/0883073813488827.23666037Open DOISearch in Google Scholar
Thouin A., Crompton D.E.: GLUT1 deficiency syndrome: Absence epilepsy and La Soupe du Jour. Pract. Neurol., 2016, 16: 50–52. doi: 10.1136/practneurol-2015-001194.ThouinA.CromptonD.E.: GLUT1 deficiency syndrome: Absence epilepsy and La Soupe du Jour. Pract. Neurol., 2016, 16: 50–52. doi: 10.1136/practneurol-2015-001194.26336901Open DOISearch in Google Scholar
Ułamek-Kozioł M., Pluta R., Bogucka-Kocka A., Czuczwar S.J.: To treat or not to treat drug-refractory epilepsy by the ketogenic diet? That is the question. Ann. Agric. Environ. Med., 2016, 23: 533–536. doi:10.5604/12321966.1226841.Ułamek-KoziołM.PlutaR.Bogucka-KockaA.CzuczwarS.J.: To treat or not to treat drug-refractory epilepsy by the ketogenic diet? That is the question. Ann. Agric. Environ. Med., 2016, 23: 533–536. doi:10.5604/12321966.1226841.28030918Open DOISearch in Google Scholar
van Baalen A., Vezzani A., Häusler M., Kluger G.: Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics, 2017, 48: 5–18. doi: 10.1055/s-0036-1597271.van BaalenA.VezzaniA.HäuslerM.KlugerG.: Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics, 2017, 48: 5–18. doi: 10.1055/s-0036-1597271.27919115Open DOISearch in Google Scholar
van der Louw E., van den Hurk D., Neal E., Leiendecker B., Fitzsimmon G., Dority L. et al.: Ketogenic diet guidelines for infants with refractory epilepsy. Eur. J. Paediatr. Neurol., 2016, 20: 798–809. doi: 10.1016/j.ejpn.2016.07.009.van der LouwE.van den HurkD.NealE.LeiendeckerB.FitzsimmonG.DorityL.: Ketogenic diet guidelines for infants with refractory epilepsy. Eur. J. Paediatr. Neurol., 2016, 20: 798–809. doi: 10.1016/j.ejpn.2016.07.009.27470655Open DOISearch in Google Scholar
van der Louw E.J., Williams T.J., Henry-Barron B.J., Olieman J.F., Duvekot J.J., Vermeulen M.J. et al.: Ketogenic diet therapy for epilepsy during pregnancy: A case series. Seizure, 2017, 45: 198–201. doi: 10.1016/j.seizure.2016.12.019.van der LouwE.J.WilliamsT.J.Henry-BarronB.J.OliemanJ.F.DuvekotJ.J.VermeulenM.J.: Ketogenic diet therapy for epilepsy during pregnancy: A case series. Seizure, 2017, 45: 198–201. doi: 10.1016/j.seizure.2016.12.019.28110175Open DOISearch in Google Scholar
Vezyroglou K., Cross J.H.: Target Treatment in Childhood Epilepsy Syndromes. Curr. Treat. Options Neurol., 2016, 18: 29. doi: 10.1007/s11940-016-0407-4.VezyroglouK.CrossJ.H.: Target Treatment in Childhood Epilepsy Syndromes. Curr. Treat. Options Neurol., 2016, 18: 29. doi: 10.1007/s11940-016-0407-4.485984527154366Open DOISearch in Google Scholar
Vining E.P., Freeman J.M., Ballaban-Gil K., Camfield C.S., Camfield P.R., Holmes G.L. et al.: A multi-center study of the efficacy of the ketogenic diet. Arch. Neurol., 1998, 55: 1433–1437.ViningE.P.FreemanJ.M.Ballaban-GilK.CamfieldC.S.CamfieldP.R.HolmesG.L.: A multi-center study of the efficacy of the ketogenic diet. Arch. Neurol., 1998, 55: 1433–1437.10.1001/archneur.55.11.14339823827Search in Google Scholar
Walczyk T., Wick J.Y.: The ketogenic diet: making a comeback. Consult. Pharm., 2017, 32: 388–396. doi: 10.4140/TCP.n.2017.388.WalczykT.WickJ.Y.: The ketogenic diet: making a comeback. Consult. Pharm., 2017, 32: 388–396. doi: 10.4140/TCP.n.2017.388.28701250Open DOISearch in Google Scholar
Wang T.T., Zhou D.: Non-invasive treatment options for focal cortical dysplasia. Exp. Ther. Med., 2016, 11: 1537–1541. doi: 10.3892/etm.2016.3100.WangT.T.ZhouD.: Non-invasive treatment options for focal cortical dysplasia. Exp. Ther. Med., 2016, 11: 1537–1541. doi: 10.3892/etm.2016.3100.484071827168769Open DOISearch in Google Scholar
Wexler I.D., Hemalatha S.G., McConnell J., Buist N.R., Dahl H.H., Berry S.A. et al: Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Neurology, 1997, 49: 1655–1661.WexlerI.D.HemalathaS.G.McConnellJ.BuistN.R.DahlH.H.BerryS.A.: Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Neurology, 1997, 49: 1655–1661.10.1212/WNL.49.6.16559409363Search in Google Scholar
Wheless J.W.: History of the ketogenic diet. Epilepsia, 2008, 49 (Suppl. 8): 3–5. doi: 10.1111/j.1528-1167.2008.01821.x.WhelessJ.W.: History of the ketogenic diet. Epilepsia, 2008, 49 (Suppl. 8): 3–5. doi: 10.1111/j.1528-1167.2008.01821.x.19049574Open DOISearch in Google Scholar
Wijnen B.F.M., de Kinderen R.J.A., Lambrechts D.A.J.E., Postulart D., Aldenkamp A.P., Majoie M.H.J.M., Evers S.M.A.A.: Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy. Epilepsy Res., 2017, 132: 91–99. doi: 10.1016/j.eplepsyres.2017.03.002.WijnenB.F.M.de KinderenR.J.A.LambrechtsD.A.J.E.PostulartD.AldenkampA.P.MajoieM.H.J.M.EversS.M.A.A.: Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy. Epilepsy Res., 2017, 132: 91–99. doi: 10.1016/j.eplepsyres.2017.03.002.28364726Open DOISearch in Google Scholar
Wilmshurst J.M., Gaillard W.D., Vinayan K.P., Tsuchida T.N., Plouin P., Van Bogaert P. et al.: Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia, 2015(a), 56: 1185–1197. doi: 10.1111/epi.13057.WilmshurstJ.M.GaillardW.D.VinayanK.P.TsuchidaT.N.PlouinP.Van BogaertP.: Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia, 2015(a), 56: 1185–1197. doi: 10.1111/epi.13057.26122601Open DOISearch in Google Scholar
Wilmshurst J.M., Burman R., Gaillard W.D., Cross J.H.: Treatment of infants with epilepsy: Common practices around the world. Epilepsia, 2015(b), 56: 1033–1046. doi: 10.1111/epi.13003.WilmshurstJ.M.BurmanR.GaillardW.D.CrossJ.H.: Treatment of infants with epilepsy: Common practices around the world. Epilepsia, 2015(b), 56: 1033–1046. doi: 10.1111/epi.13003.25963534Open DOISearch in Google Scholar
Yoon J.R., Lee E.J., Kim H.D., Lee J.H., Kang H.C.: Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy. Brain Dev., 2014, 36: 163–166. doi: 10.1016/j.braindev.2013.01.017.YoonJ.R.LeeE.J.KimH.D.LeeJ.H.KangH.C.: Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy. Brain Dev., 2014, 36: 163–166. doi: 10.1016/j.braindev.2013.01.017.23465587Open DOISearch in Google Scholar
Yoon J.R., Kim H.D., Kang H.C.: Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy. Korean J. Pediatr., 2013, 56: 327–331. doi: 10.3345/kjp.2013.56.8.327.YoonJ.R.KimH.D.KangH.C.: Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy. Korean J. Pediatr., 2013, 56: 327–331. doi: 10.3345/kjp.2013.56.8.327.376425624019842Open DOISearch in Google Scholar
Youngson N.A., Morris M.J., Ballard J.W.O.: The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs. Seizure, 2017, 52: 15–19. doi: 10.1016/j.seizure.2017.09.005.YoungsonN.A.MorrisM.J.BallardJ.W.O.: The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs. Seizure, 2017, 52: 15–19. doi: 10.1016/j.seizure.2017.09.005.28941398Open DOISearch in Google Scholar
Yuen A.W.C., Walcutt I.A., Sander J.W.: An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy. Epilepsy Behav., 2017, 74: 15–21. doi: 10.1016/j.yebeh.2017.05.032.YuenA.W.C.WalcuttI.A.SanderJ.W.: An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy. Epilepsy Behav., 2017, 74: 15–21. doi: 10.1016/j.yebeh.2017.05.032.28667864Open DOISearch in Google Scholar
Zamani G.R., Mohammadi M., Ashrafi M.R., Karimi P., Mahmoudi M., Badv R.S. et al.: The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol. Belg., 2016, 116: 529–534. doi: 10.1007/s13760-016-0601-x.ZamaniG.R.MohammadiM.AshrafiM.R.KarimiP.MahmoudiM.BadvR.S.: The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol. Belg., 2016, 116: 529–534. doi: 10.1007/s13760-016-0601-x.26791878Open DOISearch in Google Scholar
Zhang Y., Wang Y., Zhou Y., Zhang L., Yu L., Zhou S.: Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome. Epilepsy Res., 2016, 128: 176–180. doi: 10.1016/j.eplepsyres.2016.11.003.ZhangY.WangY.ZhouY.ZhangL.YuL.ZhouS.: Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome. Epilepsy Res., 2016, 128: 176–180. doi: 10.1016/j.eplepsyres.2016.11.003.27846468Open DOISearch in Google Scholar
Zhang Y., Xu J., Zhang Y., Yang W., Li B.: The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms. Curr. Neuropharmacol., 2018, 16: 66–70. doi: 10.2174/1570159X15666170517153509.ZhangY.XuJ.ZhangY.YangW.LiB.: The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms. Curr. Neuropharmacol., 2018, 16: 66–70. doi: 10.2174/1570159X15666170517153509.577138628521671Open DOISearch in Google Scholar
Zhu D., Wang M., Wang J., Yuan J., Niu G., Zhang G. et al: Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study. Epilepsy Behav., 2016, 55: 87–91. doi: 10.1016/j.yebeh.2015.12.011.ZhuD.WangM.WangJ.YuanJ.NiuG.ZhangG.: Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study. Epilepsy Behav., 2016, 55: 87–91. doi: 10.1016/j.yebeh.2015.12.011.26773676Open DOISearch in Google Scholar
Zupec-Kania B., Neal E., Schultz R., Roan M.E., Turner Z., Welborn M.: An update on diets in clinical practice. J. Child. Neurol., 2013, 28: 1015–1026. doi: 10.1177/0883073813487597.Zupec-KaniaB.NealE.SchultzR.RoanM.E.TurnerZ.WelbornM.: An update on diets in clinical practice. J. Child. Neurol., 2013, 28: 1015–1026. doi: 10.1177/0883073813487597.23674231Open DOISearch in Google Scholar
